ArticleFrontiers in cardiovascular medicine2026
Higher remnant cholesterol to lymphocyte ratio is associated with vulnerable plaque features in acute coronary syndrome.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Remnant cholesterol to lymphocyte ratio (RCLR) integrates atherogenic lipid metabolism and systemic inflammation, potentially reflecting plaque vulnerability in acute coronary syndrome (ACS). However, its association with intracoronary imaging features remains unclear. This study aimed to investigate the relationship between RCLR and culprit plaque characteristics using optical coherence tomography (OCT). Methods: This retrospective study analyzed 450 ACS inpatients (2021-2024), with 201 included after rigorous selection. The patients were classified into three groups based on the remnant cholesterol to lymphocyte ratio [RCLR; remnant cholesterol (RC = TC-HDL-C-LDL-C) divided by lymphocyte percentage], using tertiles: Group T1 (RCLR ≤ 3.03, Results: OCT imaging analysis revealed significant differences in qualitative features among various RCLR groups, including plaque rupture, lipid plaque, thin-cap fibroatheroma (TCFA), and superficial calcification (all Conclusion: In ACS patients, a higher RCLR was associated with high-risk plaque characteristics detected by OCT, such as lipid-rich plaques, TCFA, and plaque rupture, and the highest RCLR tertile remained associated with these features after multivariable adjustment. RCLR exhibits a certain predictive ability for these vulnerable plaque features. Higher RCLR tertiles were associated with a greater prevalence of vulnerable plaque features, suggesting that RCLR may serve as a composite lipid-inflammatory marker associated with coronary plaque vulnerability, although its signal partly overlaps with systemic inflammatory-cell parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.